position: EnglishChannel > Visual?Stories > Article

China publishes white paper on fight against COVID-19

Source: XINHUA| 2020-06-07 19:32:16| Author: XINHUA

China publishes white paper on fight against COVID-19

Xinhua丨Updated: June 7, 2020



A press conference is held by the State Council Information Office in Beijing, capital of China, June 7, 2020. China on Sunday issued a white paper on the country's battle against COVID-19. The white paper, titled "Fighting COVID-19: China in Action," was issued by the State Council Information Office. [Photo/Xinhua]

The white paper, titled "Fighting COVID-19: China in Action," was issued by the State Council Information Office.

The Chinese government released the white paper to keep a record of the country's efforts in its own fight against the virus, to share its experience with the rest of the world, and to clarify its ideas on the global battle, according to the white paper.

The COVID-19 global pandemic is the most extensive to afflict humanity in a century, it said.

Facing the "unknown, unexpected, and devastating disease," China launched a resolute battle to prevent and control its spread, the white paper said.

Making people's lives and health its first priority, China adopted extensive, stringent, and thorough containment measures, and has for now succeeded in cutting all channels for the transmission of the virus, it added.

Besides the foreword and afterword, the white paper consists of four parts: "China's Fight against the Epidemic: A Test of Fire," "Well-Coordinated Prevention, Control and Treatment," "Assembling a Powerful Force to Beat the Virus," and "Building a Global Community of Health for All."

Editor:房琳琳

Top News

  • On July 26, China's domestically developed amphibious aircraft, the AG600 Kunlong, took off from Rizhao Shanzihe Airport on a clear day. It successfully completed its first sea-based test flight off the coast of Qingdao in Shandong province, flying for a total of 1 hour and 21 minutes.

Researchers discover mechanism that makes COVID-19 more severe in diabetics

Brazilian researchers have discovered one of the causes of severe COVID-19 in diabetic patients. Laboratory experiments showed that the higher level of blood sugar in these patients is captured by monocytes, a type of defense cell, and serves as a source of additional energy for the coronavirus to replicate more than in a healthy organism. In response to the increased viral load, the monocytes release large amounts of pro-inflammatory cytokines with several effects including lung cell death.

A Future to Expect: International S&T Community Expresses High Hope in Cooperation with Peers in China

According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.

Copyright ? Science and Technology Daily, All Rights Reserved

mailto: yuhy@stdaily.com